Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Latinas' knowledge of and experiences with genetic cancer risk assessment: Barriers and facilitators.

Gómez-Trillos S, Sheppard VB, Graves KD, Song M, Anderson L, Ostrove N, Lopez K, Campos C, Gonzalez N, Hurtado-de-Mendoza A.

J Genet Couns. 2019 Dec 27. doi: 10.1002/jgc4.1201. [Epub ahead of print]

PMID:
31883202
2.

Culturally Targeted Video Improves Psychosocial Outcomes in Latina Women at Risk of Hereditary Breast and Ovarian Cancer.

Hurtado-de-Mendoza A, Graves KD, Gómez-Trillos S, Carrera P, Campos C, Anderson L, Luta G, Peshkin BN, Schwartz MD, Cupertino AP, Gonzalez N, Sheppard VB.

Int J Environ Res Public Health. 2019 Nov 29;16(23). pii: E4793. doi: 10.3390/ijerph16234793.

3.

The Genetic Education for Men (GEM) Trial: Development of Web-Based Education for Untested Men in BRCA1/2-Positive Families.

Peshkin BN, Ladd MK, Isaacs C, Segal H, Jacobs A, Taylor KL, Graves KD, O'Neill SC, Schwartz MD.

J Cancer Educ. 2019 Aug 11. doi: 10.1007/s13187-019-01599-y. [Epub ahead of print]

PMID:
31402434
4.

Developing a culturally targeted video to enhance the use of genetic counseling in Latina women at increased risk for hereditary breast and ovarian cancer.

Hurtado-de-Mendoza A, Graves KD, Gómez-Trillos S, Song M, Anderson L, Campos C, Carrera P, Ostrove N, Peshkin BN, Schwartz MD, Ficca N, Cupertino AP, Gonzalez N, Otero A, Huerta E, Sheppard VB.

J Community Genet. 2020 Jan;11(1):85-99. doi: 10.1007/s12687-019-00423-w. Epub 2019 May 18.

PMID:
31104207
5.

Behavioral and social scientists' reflections on genomics: a systematic evaluation within the Society of Behavioral Medicine.

McBride CM, Graves KD, Kaphingst KA, Allen CG, Wang C, Arredondo E, Klein WMP.

Transl Behav Med. 2019 Nov 25;9(6):1012-1019. doi: 10.1093/tbm/ibz044.

PMID:
30950497
6.

Screening for psychosocial distress among patients with cancer: implications for clinical practice, healthcare policy, and dissemination to enhance cancer survivorship.

Ehlers SL, Davis K, Bluethmann SM, Quintiliani LM, Kendall J, Ratwani RM, Diefenbach MA, Graves KD.

Transl Behav Med. 2019 Mar 1;9(2):282-291. doi: 10.1093/tbm/iby123.

8.

Introduction to the Special Issue on Clinical and Public Health Genomics: Opportunities for translational behavioral medicine research, practice, and policy.

Graves KD, Hall MJ, Tercyak KP.

Transl Behav Med. 2018 Jan 29;8(1):4-6. doi: 10.1093/tbm/ibx068. No abstract available.

9.

Effects and moderators of psychosocial interventions on quality of life, and emotional and social function in patients with cancer: An individual patient data meta-analysis of 22 RCTs.

Kalter J, Verdonck-de Leeuw IM, Sweegers MG, Aaronson NK, Jacobsen PB, Newton RU, Courneya KS, Aitken JF, Armes J, Arving C, Boersma LJ, Braamse AMJ, Brandberg Y, Chambers SK, Dekker J, Ell K, Ferguson RJ, Gielissen MFM, Glimelius B, Goedendorp MM, Graves KD, Heiney SP, Horne R, Hunter MS, Johansson B, Kimman ML, Knoop H, Meneses K, Northouse LL, Oldenburg HS, Prins JB, Savard J, van Beurden M, van den Berg SW, Brug J, Buffart LM.

Psychooncology. 2018 Apr;27(4):1150-1161. doi: 10.1002/pon.4648. Epub 2018 Mar 15. Review.

10.

Biospecimen donation among black and white breast cancer survivors: opportunities to promote precision medicine.

Sheppard VB, Hurtado-de-Mendoza A, Zheng YL, Wang Y, Graves KD, Lobo T, Xu H, Jennings Y, Tolsma D, Trout M, Robinson BE, McKinnon B, Tadesse M.

J Cancer Surviv. 2018 Feb;12(1):74-81. doi: 10.1007/s11764-017-0646-8. Epub 2017 Nov 16.

PMID:
29147853
11.

Long-term follow-up of mind-body medicine practices among medical school graduates.

Staffaroni A, Rush CL, Graves KD, Hendrix K, Haramati A, Harazduk N.

Med Teach. 2017 Dec;39(12):1275-1283. doi: 10.1080/0142159X.2017.1372562. Epub 2017 Sep 21.

PMID:
28933240
12.

Insights into BRCA1/2 Genetic Counseling from Ethnically Diverse Latina Breast Cancer Survivors.

Rajpal N, Muñoz J, Peshkin BN, Graves KD.

J Genet Couns. 2017 Dec;26(6):1221-1237. doi: 10.1007/s10897-017-0096-5. Epub 2017 Apr 4.

PMID:
28374142
13.

"The song inside": "La canción por dentro"-Individual and dyadic impact of breast cancer for caregivers of Latina survivors.

Munoz J, Rush C, Flashner B, Cibrian G, Martinez S, Campos C, Torres M, Cepeda O, Kuo C, Kaltman S, Jandorf L, Graves KD.

Psychooncology. 2017 Oct;26(10):1700-1703. doi: 10.1002/pon.4326. Epub 2017 Feb 1. No abstract available.

PMID:
27891712
14.

Genomic Disparities in Breast Cancer Among Latinas.

Lynce F, Graves KD, Jandorf L, Ricker C, Castro E, Moreno L, Augusto B, Fejerman L, Vadaparampil ST.

Cancer Control. 2016 Oct;23(4):359-372.

15.

Complementary and Alternative Medicine Use and Latina Breast Cancer Survivors' Symptoms and Functioning.

Rush CL, Lobo T, Serrano A, Blasini M, Campos C, Graves KD.

Healthcare (Basel). 2016 Oct 31;4(4). pii: E80.

16.

Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer.

Jacobs AS, Schwartz MD, Valdimarsdottir H, Nusbaum RH, Hooker GW, DeMarco TA, Heinzmann JE, McKinnon W, McCormick SR, Davis C, Forman AD, Lebensohn AP, Dalton E, Tully DM, Graves KD, Similuk M, Kelly S, Peshkin BN.

Fam Cancer. 2016 Oct;15(4):529-39. doi: 10.1007/s10689-016-9900-x.

17.

Patient preference and decision-making for initiating metastatic colorectal cancer medical treatment.

Fu AZ, Graves KD, Jensen RE, Marshall JL, Formoso M, Potosky AL.

J Cancer Res Clin Oncol. 2016 Mar;142(3):699-706. doi: 10.1007/s00432-015-2073-4. Epub 2015 Nov 18.

18.

Patient Perceptions of Telephone vs. In-Person BRCA1/BRCA2 Genetic Counseling.

Peshkin BN, Kelly S, Nusbaum RH, Similuk M, DeMarco TA, Hooker GW, Valdimarsdottir HB, Forman AD, Joines JR, Davis C, McCormick SR, McKinnon W, Graves KD, Isaacs C, Garber J, Wood M, Jandorf L, Schwartz MD.

J Genet Couns. 2016 Jun;25(3):472-82. doi: 10.1007/s10897-015-9897-6. Epub 2015 Oct 12.

19.

Public perceptions of disease severity but not actionability correlate with interest in receiving genomic results: nonalignment with current trends in practice.

Graves KD, Sinicrope PS, McCormick JB, Zhou Y, Vadaparampil ST, Lindor NM.

Public Health Genomics. 2015;18(3):173-83. doi: 10.1159/000375479. Epub 2015 Mar 12.

20.

Introduction to the special series on health disparities in genomic medicine.

Graves KD, Tercyak KP.

Health Psychol. 2015 Feb;34(2):97-100. doi: 10.1037/hea0000198.

PMID:
25622079
21.

Engaging Latina cancer survivors, their caregivers, and community partners in a randomized controlled trial: Nueva Vida intervention.

Rush CL, Darling M, Elliott MG, Febus-Sampayo I, Kuo C, Muñoz J, Duron Y, Torres M, Galván CC, Gonzalez F, Caicedo L, Nápoles A, Jensen RE, Anderson E, Graves KD.

Qual Life Res. 2015 May;24(5):1107-18. doi: 10.1007/s11136-014-0847-9. Epub 2014 Nov 8.

22.

Discussing race-related limitations of genomic testing for colon cancer risk: implications for education and counseling.

Butrick MN, Vanhusen L, Leventhal KG, Hooker GW, Nusbaum R, Peshkin BN, Salehizadeh Y, Pavlick J, Schwartz MD, Graves KD.

Soc Sci Med. 2014 Aug;114:26-37. doi: 10.1016/j.socscimed.2014.05.014. Epub 2014 May 15.

23.

The promise of using personalized genomic information to promote behavior change: is the debate over, or just beginning?

Graves KD, Hay JL, O'Neill SC.

Per Med. 2014 Mar;11(2):173-185. doi: 10.2217/pme.13.110.

PMID:
29751381
24.

African American women's limited knowledge and experiences with genetic counseling for hereditary breast cancer.

Sheppard VB, Graves KD, Christopher J, Hurtado-de-Mendoza A, Talley C, Williams KP.

J Genet Couns. 2014 Jun;23(3):311-22. doi: 10.1007/s10897-013-9663-6. Epub 2013 Nov 5.

25.

Communication of genetic test results to family and health-care providers following disclosure of research results.

Graves KD, Sinicrope PS, Esplen MJ, Peterson SK, Patten CA, Lowery J, Sinicrope FA, Nigon SK, Borgen J, Gorin SS, Keogh LA, Lindor NM; Behavioral Working Group of the Colon Cancer Family Registry.

Genet Med. 2014 Apr;16(4):294-301. doi: 10.1038/gim.2013.137. Epub 2013 Oct 3.

26.

Behavioral and psychosocial responses to genomic testing for colorectal cancer risk.

Graves KD, Leventhal KG, Nusbaum R, Salehizadeh Y, Hooker GW, Peshkin BN, Butrick M, Tuong W, Mathew J, Goerlitz D, Fishman MB, Shields PG, Schwartz MD.

Genomics. 2013 Aug;102(2):123-30. doi: 10.1016/j.ygeno.2013.04.002. Epub 2013 Apr 11.

27.

Translational Genomic Research: Protocol Development and Initial Outcomes following SNP Testing for Colon Cancer Risk.

Nusbaum R, Leventhal KG, Hooker GW, Peshkin BN, Butrick M, Salehizadeh Y, Tuong W, Eggly S, Mathew J, Goerlitz D, Shields PG, Schwartz MD, Graves KD.

Transl Behav Med. 2013 Mar 1;3(1):17-29. Epub 2012 Jun 10.

28.

Through the lens of culture: quality of life among Latina breast cancer survivors.

Graves KD, Jensen RE, Cañar J, Perret-Gentil M, Leventhal KG, Gonzalez F, Caicedo L, Jandorf L, Kelly S, Mandelblatt J.

Breast Cancer Res Treat. 2012 Nov;136(2):603-13. doi: 10.1007/s10549-012-2291-2. Epub 2012 Oct 21.

29.

"Is it really worth it to get tested?": primary care patients' impressions of predictive SNP testing for colon cancer.

Leventhal KG, Tuong W, Peshkin BN, Salehizadeh Y, Fishman MB, Eggly S, FitzGerald K, Schwartz MD, Graves KD.

J Genet Couns. 2013 Feb;22(1):138-51. doi: 10.1007/s10897-012-9530-x. Epub 2012 Aug 22.

30.

Psychosocial and Quality of Life in Women Receiving the 21-Gene Recurrence Score Assay: The Impact of Decision Style in Women with Intermediate RS.

Sulayman N, Spellman E, Graves KD, Peshkin BN, Isaacs C, Schwartz MD, O'Neill SC.

J Cancer Epidemiol. 2012;2012:728290. doi: 10.1155/2012/728290. Epub 2012 Jul 30.

31.

Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice.

Graves KD, Vegella P, Poggi EA, Peshkin BN, Tong A, Isaacs C, Finch C, Kelly S, Taylor KL, Luta G, Schwartz MD.

Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):445-55. doi: 10.1158/1055-9965.EPI-11-0991. Epub 2012 Feb 10.

32.

Providers' perceptions and practices regarding BRCA1/2 genetic counseling and testing in African American women.

Graves KD, Christopher J, Harrison TM, Peshkin BN, Isaacs C, Sheppard VB.

J Genet Couns. 2011 Dec;20(6):674-89. doi: 10.1007/s10897-011-9396-3. Epub 2011 Aug 6.

33.

Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance.

Schwartz MD, Isaacs C, Graves KD, Poggi E, Peshkin BN, Gell C, Finch C, Kelly S, Taylor KL, Perley L.

Cancer. 2012 Jan 15;118(2):510-7. doi: 10.1002/cncr.26294. Epub 2011 Jun 29.

34.

Quality of life among immigrant Latina breast cancer survivors: realities of culture and enhancing cancer care.

Lopez-Class M, Perret-Gentil M, Kreling B, Caicedo L, Mandelblatt J, Graves KD.

J Cancer Educ. 2011 Dec;26(4):724-33. doi: 10.1007/s13187-011-0249-4.

35.

Interest in genetic testing for modest changes in breast cancer risk: implications for SNP testing.

Graves KD, Peshkin BN, Luta G, Tuong W, Schwartz MD.

Public Health Genomics. 2011;14(3):178-89. doi: 10.1159/000324703. Epub 2011 Apr 2.

36.

BRCA1/2 genetic testing uptake and psychosocial outcomes in men.

Graves KD, Gatammah R, Peshkin BN, Krieger A, Gell C, Valdimarsdottir HB, Schwartz MD.

Fam Cancer. 2011 Jun;10(2):213-23. doi: 10.1007/s10689-011-9425-2.

37.

Job satisfaction in cancer prevention and control: a survey of the American Society of Preventive Oncology.

O'Neill SC, Thompson CL, Kapp JM, Worthington JL, Graves KD, Madlensky L.

Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):2110-2. doi: 10.1158/1055-9965.EPI-10-0629. No abstract available.

38.

BRCA1/2 test results impact risk management attitudes, intentions, and uptake.

O'Neill SC, Valdimarsdottir HB, Demarco TA, Peshkin BN, Graves KD, Brown K, Hurley KE, Isaacs C, Hecker S, Schwartz MD.

Breast Cancer Res Treat. 2010 Dec;124(3):755-64. doi: 10.1007/s10549-010-0881-4. Epub 2010 Apr 10.

39.

Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers.

Graves KD, Wenzel L, Schwartz MD, Luta G, Wileyto P, Narod S, Peshkin BN, Marcus A, Cella D, Emsbo SP, Barnes D, Halbert CH.

Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):648-54. doi: 10.1158/1055-9965.EPI-09-0548. Epub 2010 Mar 3.

40.

Perceived risk of breast cancer among Latinas attending community clinics: risk comprehension and relationship with mammography adherence.

Graves KD, Huerta E, Cullen J, Kaufman E, Sheppard V, Luta G, Isaacs C, Schwartz MD, Mandelblatt J.

Cancer Causes Control. 2008 Dec;19(10):1373-82. doi: 10.1007/s10552-008-9209-7. Epub 2008 Aug 15.

41.

Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trial.

Peshkin BN, Demarco TA, Graves KD, Brown K, Nusbaum RH, Moglia D, Forman A, Valdimarsdottir H, Schwartz MD.

Genet Test. 2008 Mar;12(1):37-52. doi: 10.1089/gte.2006.0525.

PMID:
18373403
42.

Implementing an expressive writing study in a cancer clinic.

Morgan NP, Graves KD, Poggi EA, Cheson BD.

Oncologist. 2008 Feb;13(2):196-204.

43.

Predictors of enrollment into a familial cancer registry by individuals at high risk for BRCA1/2.

Graves KD, Moss LM, Jasper CL, DeMarco TA, Peshkin BN, Isaacs C, Schwartz MD.

Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2763-7.

44.

Assessing perceptions of cancer risk: does mode of assessment or numeracy matter?

Kelly KM, Graves KD, Harper FW, Schmidt JE, Dickinson SL, Andrykowski MA.

Cancer Detect Prev. 2007;31(6):465-73.

PMID:
18061368
45.

Abnormal ovarian cancer screening test result: women's informational, psychological and practical needs.

Ryan PY, Graves KD, Pavlik EJ, Andrykowski MA.

J Psychosoc Oncol. 2007;25(4):1-18.

PMID:
18032262
46.

Distress screening in a multidisciplinary lung cancer clinic: prevalence and predictors of clinically significant distress.

Graves KD, Arnold SM, Love CL, Kirsh KL, Moore PG, Passik SD.

Lung Cancer. 2007 Feb;55(2):215-24. Epub 2006 Nov 3.

47.

Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors.

Graves KD, Peshkin BN, Halbert CH, DeMarco TA, Isaacs C, Schwartz MD.

Breast Cancer Res Treat. 2007 Sep;104(3):321-9. Epub 2006 Oct 26.

48.

The role of social cognitive processing theory and optimism in positive psychosocial and physical behavior change after cancer diagnosis and treatment.

K Harper FW, Schmidt JE, Beacham AO, Salsman JM, Averill AJ, Graves KD, Andrykowski MA.

Psychooncology. 2007 Jan;16(1):79-91.

PMID:
16915564
50.

Quality of life pilot intervention for breast cancer patients: use of social cognitive theory.

Graves KD, Carter CL, Anderson ES, Winett RA.

Palliat Support Care. 2003 Jun;1(2):121-34.

PMID:
16594274

Supplemental Content

Loading ...
Support Center